Newly diagnosed, chronic phase Chronic myeloid leukemia
Also known as: Newly diagnosed chronic phase Chronic myeloid leukemia
Drug | Drug Name | Drug Description |
---|---|---|
DB00619 | Imatinib | A tyrosine kinase inhibitor used to treat a number of leukemias, myelodysplastic/myeloproliferative disease, systemic mastocytosis, hypereosinophilic syndrome, dermatofibrosarcoma protuberans, and gastrointestinal stromal tumors. |
DB04868 | Nilotinib | A kinase inhibitor used for the chronic phase treatment of Chronic Myeloid Leukemia (CML) that is Philadelphia chromosome positive and for the treatment of CML that is resistant to therapy containing imatinib. |
Drug | Drug Name | Phase | Status | Count |
---|